1-3 of 3
Kerstin Borgmann
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Functional p53 Is Required for Effective Telomerase Inhibition in BCRABL- Positive CML Cells in Vitro

Ute Brassat, Stefan Balabanov, Melanie Braig, Daniel Bali, Kerstin Borgmann, Tim H. Brummendorf
Journal: Blood
Blood (2008) 112 (11): 572.
https://doi.org/10.1182/blood.V112.11.572.572
Published: 2008
Journal Articles

Effective Telomerase Inhibition Via Expression of Dominant-Negative HTERT Leads to Altered Growth Kinetics, Elevated Apoptosis and Increased Radiosensitivity of Bcr-Abl-Positive K562 Cells In Vitro.

Ute Brassat, Stefan Balabanov, M.D., Ph.D., Henning Wege, M.D., Daniel Roessler, Kerstin Borgmann, M.D., Tim Brummendorf, MD
Journal: Blood
Blood (2007) 110 (11): 2935.
https://doi.org/10.1182/blood.V110.11.2935.2935
Published: 2007
Journal Articles

Characterization of Bcr-Abl Positive Leukemic Cells under Long-Term In Vitro Treatment with Telomerase Inhibitor BIBR1532.

Ute Brassat, Stefan Balabanov, MD/PhD, Ulrike Hartmann, PhD, Daniel RoĢˆssler, Kerstin Borgmann, PhD, Judith Dierlamm, MD/PhD, Tim H. Brummendorf, MD
Journal: Blood
Blood (2006) 108 (11): 2185.
https://doi.org/10.1182/blood.V108.11.2185.2185
Published: 2006